These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7748183)

  • 1. Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase.
    Cook PN; Ward WH; Petrash JM; Mirrlees DJ; Sennitt CM; Carey F; Preston J; Brittain DR; Tuffin DP; Howe R
    Biochem Pharmacol; 1995 Apr; 49(8):1043-9. PubMed ID: 7748183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2,6-Dimethylphenylsulphonyl)nitromethane: a new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding site.
    Ward WH; Cook PN; Mirrlees DJ; Brittain DR; Preston J; Carey F; Tuffin DP; Howe R
    Biochem Pharmacol; 1991 Nov; 42(11):2115-23. PubMed ID: 1958230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
    Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aldose reductase by (2,6-dimethylphenylsulphonyl)nitromethane: possible implications for the nature of an inhibitor binding site and a cause of biphasic kinetics.
    Ward WH; Cook PN; Mirrlees DJ; Brittain DR; Preston J; Carey F; Tuffin DP; Howe R
    Adv Exp Med Biol; 1993; 328():301-11. PubMed ID: 8493907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
    Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.
    Cotter MA; Mirrlees DJ; Cameron NE
    Eur J Pharmacol; 2001 Apr; 417(3):223-30. PubMed ID: 11334854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase: a window to the treatment of diabetic complications?
    Crabbe MJ; Goode D
    Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.
    Vander Jagt DL; Robinson B; Taylor KK; Hunsaker LA
    J Biol Chem; 1992 Mar; 267(7):4364-9. PubMed ID: 1537826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
    Carper DA; Hohman TC; Old SE
    Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine lens aldehyde reductase (aldose reductase). Purification, kinetics and mechanism.
    Halder AB; Crabbe MJ
    Biochem J; 1984 Apr; 219(1):33-9. PubMed ID: 6426471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhibitors of aldose reductase: anti-oximes of aromatic aldehydes.
    Shen C; Sigman DS
    Arch Biochem Biophys; 1991 May; 286(2):596-603. PubMed ID: 1910296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of aldose reductase and aldehyde reductase from human kidney.
    Ansari NH; Bhatnagar A; Liu SQ; Srivastava SK
    Biochem Int; 1991 Nov; 25(4):755-65. PubMed ID: 1815509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic inhibition of aldose reductase.
    Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldose reductase by maesanin and related p-benzoquinone derivatives and effects on other enzymes.
    Haraguchi H; Ohmi I; Kubo I
    Bioorg Med Chem; 1996 Jan; 4(1):49-53. PubMed ID: 8689238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
    Vartanov SS; Pavlov AR; Iaropolov AI
    Biokhimiia; 1990 Nov; 55(11):2046-57. PubMed ID: 2128191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.